Biotech NewsCERO Stock Price Targets $45—But Reality Sits at $6.93 BioTech Health XSeptember 5, 2025 CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) is a clinical-stage biotechnology company based in South San Francisco, California, that is… 0 Shares 0 0 0 0 0 0 0